A new metric of antibiotic class resistance in gram-negative bacilli isolated from hospitalized children

Infection Control and Hospital Epidemiology

Volumn 33, Issue 6, 2012, Pages 602-607

  Patel, Sameer J ^a   O'Toole, Dana ^a   Larson, Elaine ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE; BETA LACTAM ANTIBIOTIC; CARBAPENEM DERIVATIVE; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ACINETOBACTER BAUMANNII; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL COLONIZATION; CHILD; CLINICAL ARTICLE; ELECTRONIC MEDICAL RECORD; ENTEROBACTER; ESCHERICHIA COLI; FEMALE; GRAM NEGATIVE BACTERIUM; GRAM NEGATIVE INFECTION; HOSPITAL ADMISSION; HOSPITALIZED CHILD; HUMAN; KLEBSIELLA; MALE; MULTIDRUG RESISTANCE; NONHUMAN; PRESCHOOL CHILD; PROTEUS; PSEUDOMONAS; SERRATIA;

ADOLESCENT; ANTI-BACTERIAL AGENTS; CHILD; CHILD, PRESCHOOL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ELECTRONIC HEALTH RECORDS; FEMALE; GRAM-NEGATIVE BACTERIA; GRAM-NEGATIVE BACTERIAL INFECTIONS; HOSPITALIZATION; HUMANS; INFANT; INFANT, NEWBORN; MALE; NEW YORK CITY; PATIENT TRANSFER; RESIDENTIAL FACILITIES; RETROSPECTIVE STUDIES;

EID: 84860666408     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/665709     Document Type: Article

References (19)

1. Kallen AJ, Hidron AI, Patel J, Srinivasan A. Multidrug resistance among gram-negative pathogens that caused healthcare-associated infections reported to the National Healthcare Safety Network, 2006-2008. Infect Control Hosp Epidemiol 2010;31: 528-531.
2. Falagas ME, Karageorgopoulos DE. Pandrug resistance (PDR), extensive drug resistance (XDR), and multidrug resistance (MDR) among gram-negative bacilli: need for international harmonization in terminology. Clin Infect Dis 2008;46:1121-1122.
3. Lidsky K, Hoyen C, Salvator A, Rice LB, Toltzis P. Antibioticresistant gram-negative organisms in pediatric chronic-care facilities. Clin Infect Dis 2002;34:760-766.
4. Zaoutis TE, Goyal M, Chu JH, et al. Risk factors for and outcomes of bloodstream infection caused by extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species in children. Pediatrics 2005;115:942-949.
5. Kim YK, Pai H, Lee HJ, et al. Bloodstream infections by extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in children: epidemiology and clinical outcome. Antimicrob Agents Chemother 2002;46:1481-1491.
6. Abdel-Hady H, Hawas S, El-Daker M, El-Kady R. Extendedspectrum beta-lactamase producing Klebsiella pneumoniae in neonatal intensive care unit. J Perinatol 2008;28:685-690.
7. Arnoni MV, Berezin EN, Martino MD. Risk factors for nosocomial bloodstream infection caused by multidrug resistant gram-negative bacilli in pediatrics. Braz J Infect Dis 2007;11: 267-271.
8. Furuya EY, Lowy FD. Antimicrobial-resistant bacteria in the community setting. Nat Rev Microbiol 2006;4:36-45.
9. Mandar A, Neidell M, Yoko Furuya E, Caplan D, Glied S, Larson E. Using electronically available inpatient hospital data for research. Clin Translational Sci J 2011;4:338-345.
10. Clinical and Laboratory Standards Institute (CLSI). Cephalosporin and Aztreonam Breakpoint Revisions Fact Sheet. Wayne, PA: CLSI, 2010. CLSI document M100-S20. http://www.clsi.org/ Content/NavigationMenu/Committees/Microbiology/AST/ CephalosporinandAztreonamBreakpointRevisionFactSheet/ CephalosporinAztreonamBreakpointFactSheet.pdf. Accessed September 15, 2011.
11. Samra Z, Ofir O, Lishtzinsky Y, Madar-Shapiro L, Bishara J. Outbreak of carbapenem-resistant Klebsiella pneumoniae producing KPC-3 in a tertiary medical centre in Israel. Int J Antimicrob Agents 2007;30:525-529.
12. Guidance for control of infections with carbapenem-resistant or carbapenemase-producing Enterobacteriaceae in acute care facilities. MMWR Morb Mortal Wkly Rep 2009;58:256-260.
13. Huang SS, Yokoe DS, Stelling J, et al. Automated detection of infectious disease outbreaks in hospitals: a retrospective cohort study. PLoS Med 2010;7:e1000238.
14. Morgan DJ, Day HR, Furuno JP, et al. Improving efficiency in active surveillance for methicillin-resistant Staphylococcus aureus or vancomycin-resistant Enterococcus at hospital admission. Infect Control Hosp Epidemiol 2010;31:1230-1235.
15. Bertrand X, Thouverez M, Talon D, et al. Endemicity, molecular diversity and colonisation routes of Pseudomonas aeruginosa in intensive care units. Intens Care Med 2001;27:1263-1268.
16. Harris AD, Perencevich EN, Johnson JK, et al. Patient-to-patient transmission is important in extended-spectrumbeta-lactamaseproducing Klebsiella pneumoniae acquisition. Clin Infect Dis 2007;45:1347-1350.
17. Harris AD, Kotetishvili M, Shurland S, et al. How important is patient-to-patient transmission in extended-spectrum betalactamase Escherichia coli acquisition. Am J Infect Control 2007; 35:97-101.
18. Manikal VM, Landman D, Saurina G, Oydna E, Lal H, Quale J. Endemic carbapenem-resistant Acinetobacter species in Brooklyn, New York: citywide prevalence, interinstitutional spread, and relation to antibiotic usage. Clin Infect Dis 2000;31:101-106.
19. Lopushinsky SR, Covarrubia KA, Rabeneck L, Austin PC, Urbach DR. Accuracy of administrative health data for the diagnosis of upper gastrointestinal diseases. Surg Endosc 2007;21: 1733-1737.